IRS Guidance Regarding Qualifying Therapeutic Discovery Project Credit

more+
less-

On May 21, 2010, the Internal Revenue Service released Notice 2010-45,1 which provides anticipated guidance regarding the filing of claims for a qualifying therapeutic discovery project (“QTDP”) credit. The QTDP credit is a refundable tax credit established by the recently passed Patient Protection and Affordable Care Act, and is directed at companies with not more than 250 employees that have expended money on certain biotechnology research projects.

Pryor Cashman Tax Partner Michael Dunworth and Counsel Martin Jones have written an informative Legal Update, entitled IRS Guidance Regarding Qualifying Therapeutic Discovery Project Credit, summarizing the highlights of Notice 2010-45.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Business Organization Updates, Intellectual Property Updates, Science, Computers & Technology Updates, Tax Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Pryor Cashman LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »